COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer

[1]  Richard D Cummings,et al.  Protein glycosylation in cancer. , 2015, Annual review of pathology.

[2]  J. Izbicki,et al.  ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer , 2014, Clinical Cancer Research.

[3]  J. Olsen,et al.  Immature truncated O-glycophenotype of cancer directly induces oncogenic features , 2014, Proceedings of the National Academy of Sciences.

[4]  Po-Huang Lee,et al.  The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK , 2014, Molecular carcinogenesis.

[5]  P. Jha,et al.  Correction: Factors Associated with Physician Agreement on Verbal Autopsy of over 11500 Injury Deaths in India , 2013, PLoS ONE.

[6]  K. David,et al.  Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma , 2013, International journal of cancer.

[7]  Helene K Myrvang,et al.  Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells , 2013, FEBS letters.

[8]  G. Chang,et al.  Surface a -Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target , 2013 .

[9]  B. Meyer,et al.  Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL). , 2013, Glycobiology.

[10]  S. Brunak,et al.  Precision mapping of the human O‐GalNAc glycoproteome through SimpleCell technology , 2013, The EMBO journal.

[11]  C. Leclerc,et al.  Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer , 2013, Cancer Immunology, Immunotherapy.

[12]  P. Argani,et al.  Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78 , 2013, Clinical Cancer Research.

[13]  R. Cummings,et al.  Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn Antigen , 2022 .

[14]  Xiaowei Wang,et al.  PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update , 2011, Nucleic Acids Res..

[15]  H. Wandall,et al.  Mining the O-glycoproteome using zinc-finger nuclease–glycoengineered SimpleCell lines , 2011, Nature Methods.

[16]  A. Tres,et al.  Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer. , 2011, The oncologist.

[17]  C. Borrebaeck,et al.  A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity. , 2011, Glycobiology.

[18]  J. Izbicki,et al.  Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer. , 2011, Cancer research.

[19]  K. Taniuchi,et al.  Overexpression of GalNAc-transferase GalNAc-T3 Promotes Pancreatic Cancer Cell Growth , 2011, Oncogene.

[20]  Yusuke Nakamura,et al.  Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin. , 2011, Neoplasia.

[21]  Henrik Clausen,et al.  Location, location, location: new insights into O-GalNAc protein glycosylation. , 2011, Trends in cell biology.

[22]  B. Xia,et al.  A novel fluorescent assay for T-synthase activity. , 2011, Glycobiology.

[23]  Jeremy C. Collette,et al.  Emerging Paradigms for the Initiation of Mucin-type Protein O-Glycosylation by the Polypeptide GalNAc Transferase Family of Glycosyltransferases* , 2011, The Journal of Biological Chemistry.

[24]  R. Cummings,et al.  The Tn Antigen—Structural Simplicity and Biological Complexity , 2011, Angewandte Chemie.

[25]  A. Hovanessian,et al.  Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization , 2010, PloS one.

[26]  Douglas B. Evans,et al.  High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma , 2010, Clinical Cancer Research.

[27]  R. Simon,et al.  Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung , 2010, BMC Cancer.

[28]  Leonor David,et al.  Alterations in glycosylation as biomarkers for cancer detection , 2010, Journal of Clinical Pathology.

[29]  Giovanni Parmigiani,et al.  Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers , 2009, Proceedings of the National Academy of Sciences.

[30]  A. Scarpa,et al.  An integrated humoral and cellular response is elicited in pancreatic cancer by α‐enolase, a novel pancreatic ductal adenocarcinoma‐associated antigen , 2009, International journal of cancer.

[31]  M. Anver,et al.  Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines , 2009, Molecular Cancer Therapeutics.

[32]  T. Irimura,et al.  A lectin recognizes differential arrangements of O-glycans on mucin repeats. , 2008, Biochemical and biophysical research communications.

[33]  B. Xia,et al.  Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc (Cancer Research (2008) 68, (1636-1646)) , 2008 .

[34]  B. Xia,et al.  Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. , 2008, Cancer research.

[35]  Henrik Clausen,et al.  Mucin-type O-glycosylation and its potential use in drug and vaccine development. , 2008, Biochimica et biophysica acta.

[36]  H. Müller-Hermelink,et al.  A new tumor-specific variant of GRP78 as target for antibody-based therapy , 2008, Laboratory Investigation.

[37]  G. Cavet,et al.  Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL , 2007, Nature Medicine.

[38]  E. Bennett,et al.  Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer. , 2007, Acta histochemica.

[39]  G. Meijer,et al.  The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma , 2007, Cancer Immunology, Immunotherapy.

[40]  M. Morris,et al.  A polyvalent vaccine for high-risk prostate patients: “are more antigens better?” , 2007, Cancer Immunology, Immunotherapy.

[41]  F. Real,et al.  Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. , 2007, The American journal of pathology.

[42]  Maido Remm,et al.  Enhancements and modifications of primer design program Primer3 , 2007, Bioinform..

[43]  G. Soma,et al.  Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis. , 2006, Anticancer research.

[44]  P. Azadi,et al.  A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen , 2006, Science.

[45]  I. Brockhausen,et al.  Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions , 2006, EMBO reports.

[46]  R. Cummings,et al.  Protein glycosylation: Chaperone mutation in Tn syndrome , 2005, Nature.

[47]  S. Chierici,et al.  Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines. , 2005, Bioconjugate chemistry.

[48]  D. Legrand,et al.  Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell compartment. , 2005, Biochemistry.

[49]  G. Courtand,et al.  Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration , 2005, Breast Cancer Research and Treatment.

[50]  H. Narimatsu,et al.  Expression of UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase-12 in Gastric and Colonic Cancer Cell Lines and in Human Colorectal Cancer , 2004, Oncology.

[51]  J. Le Pendu,et al.  Expression of sialyl-Tn epitopes on β1 integrin alters epithelial cell phenotype, proliferation and haptotaxis , 2004, Journal of Cell Science.

[52]  W. Arap,et al.  Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. , 2004, Cancer cell.

[53]  L. BenMohamed,et al.  A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates , 2004, Cancer Research.

[54]  R. Cummings,et al.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Crawley,et al.  Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. , 2002, Gastroenterology.

[56]  A. Nanashima,et al.  High serum concentrations of sialyl Tn antigen in carcinomas of the biliary tract and pancreas. , 1999, Journal of hepato-biliary-pancreatic surgery.

[57]  Guo‐Jun Zhang,et al.  Prognostic relevance of tn expression in Breast Cancer , 1999, Breast cancer.

[58]  G. Springer.  Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy , 1997, Journal of Molecular Medicine.

[59]  K. Hajjar,et al.  Interaction of the Fibrinolytic Receptor, Annexin II, with the Endothelial Cell Surface , 1996, The Journal of Biological Chemistry.

[60]  T. Terada,et al.  Expression of mucin carbohydrate antigens (T, Tn and sialyl Tn) and MUC-1 gene product in intraductal papillary-mucinous neoplasm of the pancreas. , 1996, American journal of clinical pathology.

[61]  E. Scanlon,et al.  Pancarcinoma T/Tn Antigen Detects Human Carcinoma Long before Biopsy Does and Its Vaccine Prevents Breast Carcinoma Recurrence a , 1993, Annals of the New York Academy of Sciences.

[62]  S. Hakomori,et al.  Expression of Tn, sialosyl Tn, and T antigens in human pancreas. , 1991, Gastroenterology.

[63]  J. Dausset,et al.  [Acquired hemolytic anemia with polyagglutinability of erythrocytes by a new factor present in normal blood]. , 1957, Bulletins et memoires de la Societe medicale des hopitaux de Paris.

[64]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[65]  C. Borrebaeck,et al.  A new murine IgG 1 anti-Tn monoclonal antibody with in vivo anti-tumor activity , 2011 .

[66]  A. Furlan,et al.  ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. , 2006, Glycobiology.

[67]  H. Makino,et al.  Serum sialyl-Tn antigen levels in patients with digestive cancers. , 1991, Oncology.

[68]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.